American Vanguard Balance Sheet Health
Financial Health criteria checks 2/6
American Vanguard has a total shareholder equity of $181.4M and total debt of $267.6M, which brings its debt-to-equity ratio to 147.5%. Its total assets and total liabilities are $635.3M and $454.0M respectively. American Vanguard's EBIT is $6.9M making its interest coverage ratio 0.3. It has cash and short-term investments of $43.9M.
Key information
147.54%
Debt to equity ratio
US$267.62m
Debt
| Interest coverage ratio | 0.3x |
| Cash | US$43.90m |
| Equity | US$181.39m |
| Total liabilities | US$453.96m |
| Total assets | US$635.34m |
Recent financial health updates
Analysis Article • Oct 30
Is American Vanguard (NYSE:AVD) Using Debt In A Risky Way?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Analysis Article • Dec 12
Is American Vanguard (NYSE:AVD) Using Too Much Debt?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...Recent updates
New Narrative • Sep 09
American Vanguard Trades at $2.28. Book Value Is $6.63. Contractual Debt Is $285 Million.
American Vanguard trades around $2.30 per share , which puts the common equity at roughly $65 million. Reported book value is about $6.63 per share.Seeking Alpha • Feb 18
American Vanguard: Making Improvements, But The Environment Remains Challenging
Summary American Vanguard continues its turnaround amid persistent end-market headwinds that have driven 2025 revenues well below initial expectations. I expect 3%-4% revenue growth in 2026 on improving input utilization and potential restocking, but acreage pressures in corn and cotton are a risk, and a V-shaped recovery is unlikely. I consider management's mid-teens EBITDA margin target ambitious; I forecast gradual improvement toward 12% over time, but that's still enough to support upside for the shares. Valuation could be attractive if end-market demand improves, but I remain cautious, awaiting 2026 guidance and clearer signs of volume demand recovery before considering an upgrade. Read the full article on Seeking AlphaAnalysis Article • Dec 18
American Vanguard Corporation's (NYSE:AVD) Share Price Is Matching Sentiment Around Its Revenues
When close to half the companies operating in the Chemicals industry in the United States have price-to-sales ratios...Analysis Article • Nov 20
At US$4.41, Is American Vanguard Corporation (NYSE:AVD) Worth Looking At Closely?
While American Vanguard Corporation ( NYSE:AVD ) might not have the largest market cap around , it received a lot of...Analysis Article • Oct 30
Is American Vanguard (NYSE:AVD) Using Debt In A Risky Way?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Analysis Article • Aug 13
American Vanguard Corporation (NYSE:AVD) Held Back By Insufficient Growth Even After Shares Climb 29%
American Vanguard Corporation ( NYSE:AVD ) shareholders would be excited to see that the share price has had a great...
New Narrative • May 09
Implementing ERP Systems And Reducing Inventory Will Streamline Processes
The ERP system and transformation plan aim to improve efficiency, enhance margins, and boost EBITDA through better cost management and operational processes.Seeking Alpha • Feb 27
American Vanguard: Can New Leadership And Restructuring Reinvigorate The Business?
Summary American Vanguard has had to deal with weaker crop protection volumes and increased generic competition that have sapped profitability and hit the share price hard. AVD's restructuring efforts aim to reduce costs, improve efficiency, and target growth, and the company recently hired a new CEO with relevant experience in post-patent crop protection. The company's efforts in biologicals (GreenSolutions) offers attractive growth potential, but may require more R&D reinvestment than the company has done in the past. I am concerned that prior targets for 15% post-restructuring EBITDA may be too ambitious, and generic competition may be persistent, but undemanding growth targets still point to significant potential upside. Despite that potential undervaluation, I prefer to see more stability and guidance/commentary from the new CEO before committing to a more bullish call on AVD. Read the full article on Seeking AlphaAnalysis Article • Feb 03
Investors Still Aren't Entirely Convinced By American Vanguard Corporation's (NYSE:AVD) Revenues Despite 33% Price Jump
American Vanguard Corporation ( NYSE:AVD ) shareholders would be excited to see that the share price has had a great...Analysis Article • Dec 20
Slammed 31% American Vanguard Corporation (NYSE:AVD) Screens Well Here But There Might Be A Catch
American Vanguard Corporation ( NYSE:AVD ) shares have had a horrible month, losing 31% after a relatively good period...Analysis Article • Dec 12
Is American Vanguard (NYSE:AVD) Using Too Much Debt?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...Analysis Article • Nov 15
Analysts Have Been Trimming Their American Vanguard Corporation (NYSE:AVD) Price Target After Its Latest Report
American Vanguard Corporation ( NYSE:AVD ) just released its latest third-quarter report and things are not looking...Analysis Article • Sep 25
These Return Metrics Don't Make American Vanguard (NYSE:AVD) Look Too Strong
Ignoring the stock price of a company, what are the underlying trends that tell us a business is past the growth phase...Analysis Article • Aug 09
Is American Vanguard Corporation (NYSE:AVD) Potentially Undervalued?
American Vanguard Corporation ( NYSE:AVD ), might not be a large cap stock, but it received a lot of attention from a...Seeking Alpha • Jul 24
American Vanguard: Panic Selloff Makes Shares Attractive
Summary 27% panic sell-off post Q1 2024 earnings, despite double-digit YoY growth in EBITDA and operating income. Over $500k value of shares bought by three insiders after the significant drop in share price. Healthy financials, with 2024 guidance indicating expectations to surpass net sales and adjusted EBITDA of 2023, despite the suspension of Dacthal sales in the US. Given these factors, and more that I will cover in this article, I rate the stock as a Strong Buy. Read the full article on Seeking AlphaAnalysis Article • Jun 16
American Vanguard (NYSE:AVD) Is Due To Pay A Dividend Of $0.03
The board of American Vanguard Corporation ( NYSE:AVD ) has announced that it will pay a dividend of $0.03 per share on...Analysis Article • Mar 16
American Vanguard (NYSE:AVD) Is Due To Pay A Dividend Of $0.03
American Vanguard Corporation ( NYSE:AVD ) has announced that it will pay a dividend of $0.03 per share on the 10th of...Seeking Alpha • Feb 04
Cove Street Capital - American Vanguard: A Unique Confluence Of Highly Favorable Factors
Summary We initiated a position in American Vanguard, a manufacturer, developer, and marketer of crop and plant protection chemicals. We have bought and sold AVD at various points throughout the last decade, but this iteration presents a unique confluence of factors. We see meaningful upside should this business return to its historically steady EBITDA margins and EV/EBITDA multiples. Read the full article on Seeking AlphaSeeking Alpha • Dec 25
American Vanguard Corporation: Large Declines In Price Don't Always Mean Value
Summary American Vanguard Corporation is involved in the development, production, and marketing of specialty chemicals for consumer, business, and agricultural demands. The company's expansion into South America has led to significant financial benefits, tapping into the growing demand for agricultural products in countries like Brazil and Argentina. This expansion has diversified American Vanguard's financial portfolio, reduced reliance on the North American market, and enhanced its global competitiveness in the agricultural chemicals industry. The firm is currently overvalued based on my DCF projections, resulting in a hold rating. Read the full article on Seeking AlphaAnalysis Article • Dec 18
American Vanguard's (NYSE:AVD) Dividend Will Be $0.03
American Vanguard Corporation's ( NYSE:AVD ) investors are due to receive a payment of $0.03 per share on 12th of...Financial Position Analysis
Short Term Liabilities: AVD's short term assets ($417.8M) exceed its short term liabilities ($168.8M).
Long Term Liabilities: AVD's short term assets ($417.8M) exceed its long term liabilities ($285.2M).
Debt to Equity History and Analysis
Debt Level: AVD's net debt to equity ratio (123.3%) is considered high.
Reducing Debt: AVD's debt to equity ratio has increased from 40.4% to 147.5% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: AVD has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: AVD has less than a year of cash runway if free cash flow continues to reduce at historical rates of 38.9% each year
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/09/14 13:07 |
| End of Day Share Price | 2026/09/14 00:00 |
| Earnings | 2026/06/30 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
American Vanguard Corporation is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Nick Genova | B. Riley Securities, Inc. |
| Benjamin Klieve | Lake Street Capital Markets, LLC |
| Brett William Wong | Piper Sandler Companies |